Patents Assigned to ANIDA PHARMA INC.
  • Methods of treating amyotrophic lateral sclerosis
    Patent number: 9340483
    Abstract: The present invention relates to use of DHA analogs and their pharmaceutical compositions for treating ALS, by administering these compounds or pharmaceutical compositions to subjects in need thereof.
    Type: Grant
    Filed: February 15, 2013
    Date of Patent: May 17, 2016
    Assignee: ANIDA PHARMA INC.
    Inventor: Per Gjorstrup
  • Methods of Treating Amyotrophic Lateral Sclerosis
    Publication number: 20150010549
    Abstract: The present invention relates to use of DHA analogs and their pharmaceutical compositions for treating ALS, by administering these compounds or pharmaceutical compositions to subjects in need thereof.
    Type: Application
    Filed: February 15, 2013
    Publication date: January 8, 2015
    Applicant: ANIDA PHARMA INC.
    Inventor: Per Gjorstrup
  • Methods of treating ototoxicity
    Patent number: RE48077
    Abstract: The present invention relates to use of DHA analogs and their pharmaceutical compositions for treating ototoxicity, by administering these compounds or pharmaceutical compositions to subjects in need thereof. Ototoxicity is defined as damage to the structures of the ear, such as the cochlea and vestibular system, by drugs or toxins. Ototoxicity can result in irreversible hearing loss, tinnitus, dysequilibrium, Meniere's disease, or vertigo.
    Type: Grant
    Filed: October 11, 2018
    Date of Patent: July 7, 2020
    Assignee: Anida Pharma Inc.
    Inventor: Per Gjorstrup